Targeting the α Receptor for Platelet-Derived Growth Factor as a Primary or Combination Therapy in a Preclinical Model of Prostate Cancer Skeletal Metastasis

Journal article

Open access

Peer reviewed

Mike R RUSSELL, QINGXIN QINGXIN LIU and Alessandro FATATIS

Clinical cancer research, v 16(20), pp 5002-5010

2010

PMID: 20813817

Files and links (1)

url

https://doi.org/10.1158/1078-0432.CCR-10-1863View

Published, Version of Record (VoR) Open

Tumors of the urinary system

Urinary tract. Prostate gland

Gynecology. Andrology. Obstetrics

Pharmacology. Drug treatments

Diseases of the osteoarticular system

Tumors of striated muscle and skeleton

Nephrology. Urinary tract diseases

Biological and medical sciences

Medical sciences

Antineoplastic agents

Male genital diseases

Tumors

12 Record Views

40 citations in Scopus

Title: Targeting the α Receptor for Platelet-Derived Growth Factor as a Primary or Combination Therapy in a Preclinical Model of Prostate Cancer Skeletal Metastasis
Creators: Mike R RUSSELL - Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
QINGXIN QINGXIN LIU - Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
Alessandro FATATIS - Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
Publication Details: Clinical cancer research, v 16(20), pp 5002-5010
Publisher: American Association for Cancer Research; Philadelphia, PA
Resource Type: Journal article
Language: English
Academic Unit: Pharmacology and Physiology
Web of Science ID: WOS:000282877700012
Scopus ID: 2-s2.0-77958057758
Other Identifier: 991014877825604721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: